Abstract
Summary
To evaluate bone mineral density (BMD) and morphometric vertebral fractures (MVF) in chronic obstructive pulmonary disease (COPD) patients in comparison with two control groups. BMD was lower in the disease group (DG) and was associated with the worst disease severity and prognosis. The prevalence of MVF was high and greater in the DG than in the control groups.
Introduction
Chronic obstructive pulmonary disease (COPD) is associated with osteoporosis and vertebral fractures. It is still unclear whether the presence of fractures and changes in bone mineral density (BMD) are associated with disease severity and prognosis. The aim of this study was to evaluate BMD and morphometric vertebral fractures (MVF) in COPD patients in comparison with two control groups and to correlate these parameters with indices of COPD severity (VEF1 and GOLD) and prognosis (BODE).
Methods
This was a cross-sectional study in COPD patients (disease group, DG) who underwent BMD and vertebral fracture assessment (VFA). Two control groups were used: smokers without COPD (smoker group, SG) and healthy never-smoker individuals (never-smoker group, NSG).
Results
The DG comprised 121 patients (65 women, mean age 67.9 ± 8.6 years). Altered BMD was observed in 88.4% of the patients in the DG, which was more prevalent when compared with the control groups (p < 0.001). The BMD values were lower in the DG than in the control groups (p < 0.05). BMD was associated with the worst disease severity and prognosis (p < 0.05). The prevalence of MVF was high (57.8%) and greater than that in the SG (23.8%) and the NSG (14.8%; p < 0.001). The prevalence of fractures was not associated with disease severity and prognosis.
Conclusions
COPD patients have a higher prevalence of MVF and low BMD, and the latter was associated with the severity and poor prognosis of the disease.
Similar content being viewed by others
References
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. National Heart, Lung and Blood Institutes. Revised 2011. www.goldcopd.com
Cielen N, Maes K, Gayan-Ramirez G (2014) Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int 2014:96576
Eagan TM, Aukrust P, Upland T, Hardier JA, Johannessen A, Mollnes TE et al (2010) Body composition and plasma levels of inflammatory biomarkers in COPD. Eur Respir J 36(5):1027–1033
Decramer M, Janssens W, Miravitlles M (2012) Chronic obstructive pulmonary disease. Lancet 379(9823):1341–1351
Miller J, Edwards LD, Agustí A, Bakke P, Calverley PM, Celli B et al (2013) Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 107(9):1376–1384
Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CA, Boguszewski CL et al (2009) Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 20(11):1881–1887
Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA (2009) Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 34:209–218
Yamamoto Y, Yoshikawa M, Tomoda K, Fujita Y, Yamauchi M, Fukuoka A et al (2014) Distribution of bone mineral content is associated with body weight and exercise capacity in patients with chronic obstructive pulmonary disease. Respiration 87(2):158–164
Fouda MA, Alhamad EH, Al-Hajjaj MS, Shaik SA, Alboukai AA, Al-Kassimi FA (2017) A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotype. Ann Thorac Med 12(2):101–106
Hamdy RC (2016) Bone mineral density and fractures. J Clin Densitom 19(2):125–126
Nuti R, Siviero P, Maggi S, Guglielmi G, Caffarelli C, Crepaldi G et al (2009) Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int 20(6):989–998
Schlaich C, Minne HW, Bruckner T (1998) Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 8:261–267
Silva DR, Coelho AC, Dumke A, Valentini JD, de Nunes JN, Stefani CL et al (2011) Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care 56(7):961–968
Ogura-Tomomatsu H, Asano K, Tomomatsu K, Miyata J, Ohmori N, Kodama M et al (2012) Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease. COPD 9(4):332–337
Koo HK, Park JH, Park HK, Jung H, Lee SS (2014) Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS One 9(10):e110448
Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL (2005) Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 128(4):2099–2107
World Health Organ (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Tech Rep Ser 894:i–xii 1–253
(2015) 6th ISCD position development conference (adult). www.iscd.org
Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D et al (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11(7):984–996
Prignot J (1987) Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis 70(1):1–7
Ferris BG (1978) Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 118(6 Pt 2):1–120
Jones PW, Harding G, Berry P (2009) Development and first validation of the COPD assessment test. Eur Respir J 34(3):648–654
Balke B (1963) A simple field test for the assessment of physical fitness. Rep 63–6. Rep Civ Aeromed Res Inst US
Celli B, Cote C, Marin J (2004) The body mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005–1012
Stern DA, Morgan WJ, Wright AL, Guerra S, Martinez FD (2007) Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 370(9589):758–764
Hunninghake GM, Cho MH, Tesfaigzi Y, Soto-Quiros ME, Avila L, Lasky-Su J, Stidley C et al (2009) MMP12, lung function, and COPD in high-risk populations. N Engl J Med 361(27):2599–2608
Pinheiro MM, Ciconelli RM, Martini LA, Ferraz MB (2009) Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study (BRAZOS). Osteoporos Int 20(3):399–408
Sakurai-Iesato Y, Kawata N, Tada Y, Iesato K, Matsuura Y, Yahaba M et al (2017) The relationship of bone mineral density in men with chronic obstructive pulmonary disease classified according to the global initiative for chronic obstructive lung disease (GOLD) combined chronic obstructive pulmonary disease (COPD) assessment system. Intern Med 56(14):1781–1790
Romme EA, Murchison JT, Edwards LD, van Beek E Jr, Murchison DM, Rutten EP et al (2013) Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) study investigators. CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes. J Bone Miner Res 28(6):1369–1377
Watanabe R, Tanaka T, Aita K, Hagiya M, Homma T, Yokosuka K et al (2015) Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab 33(4):392–400
Kjensli A, Mowinckel P, Ryg MS, Falch JA (2007) Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 40:493–497
Majumdar SR, Villa-Roel C, Lyons KJ, Rowe BH (2010) Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease. Respir Med 104(2):260–266
Graumam RQ, Pinheiro MM, Nery LE, Castro CHM (2018) Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity. Osteoporos Int 29:1457–1468. https://doi.org/10.1007/s00198-018-4483-z
Kulak CA, Borba VC, Jorgetti V, Dos Reis LM, Liu XS, Kimmel DB et al (2010) Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease. J Bone Miner Res 25(9):1931–1940
Jaramillo JD, Wilson C, Stinson DS, Lynch DA, Bowler RP, Lutz S et al (2015) Reduced bone density and vertebral fractures in smokers. Men and COPD patients at increased risk. Ann Am Thorac Soc 12(5):648–654
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Munhoz da Rocha Lemos Costa, T., Costa, F.M., Hoffman Jonasson, T. et al. Bone mineral density and vertebral fractures and their relationship with pulmonary dysfunction in patients with chronic obstructive pulmonary disease. Osteoporos Int 29, 2537–2543 (2018). https://doi.org/10.1007/s00198-018-4643-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-018-4643-1